Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Παρόμοια τεκμήρια

• Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
  ανά: Baraliakos, Xenofon, κ.ά.
  Έκδοση: (2005)
• Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis
  ανά: Braun, J, κ.ά.
  Έκδοση: (2005)
• The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
  ανά: Baraliakos, Xenofon, κ.ά.
  Έκδοση: (2008)
• Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
  ανά: Baraliakos, X, κ.ά.
  Έκδοση: (2005)
• Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab
  ανά: Baraliakos, X, κ.ά.
  Έκδοση: (2005)